{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:54:18Z","timestamp":1778615658829,"version":"3.51.4"},"reference-count":41,"publisher":"American Association for Cancer Research (AACR)","issue":"7","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Dynamic biomarkers that guide de-escalation strategies in human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) remain an unmet need. In this study, we evaluated the kinetics of plasma cell-free HPV (cfHPV) DNA and oral gargle HPV DNA during radiotherapy in patients with low-risk HPV-related OPSCC. Data were obtained from a trial evaluating an adaptive model optimizing radiation fractionation in patients with low-risk (T0-2N0-1M0) HPV-related OPSCC undergoing radiotherapy. The primary objective was to determine whether week 4 plasma cfHPV DNA or oral gargle HPV DNA clearance is associated with reduction of target tumor volume (TTV) at week 4. A total of 325 plasma and 334 oral gargle samples from 50 patients with available baseline samples were analyzed. Higher baseline plasma cfHPV DNA was associated with higher nodal staging (P = 0.002), whereas oral gargle HPV DNA was detected more frequently in the tonsil or soft palate than occult or base of tongue primary tumors (P = 0.039). Week 4 plasma but not oral gargle HPV DNA clearance was associated with higher reduction of TTV at week 4 (P = 0.0063). Whereas week 4 plasma and oral gargle HPV DNA clearance was not associated with progression-free survival, a lower baseline plasma cfHPV DNA was associated with superior progression-free survival (P = 0.027). Week 4 plasma cfHPV DNA clearance aligns with reduction in TTV, and future studies are warranted to determine the role of early plasma cfHPV DNA clearance in biomarker-adapted de-escalation strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Our findings may inform appropriate patient selection for low-risk HPV-related OPSCC based on cfHPV DNA in future deintensification studies, aimed at preventing or minimizing treatment-related toxicities in patients who may have lower risk of recurrence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0180","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T12:38:33Z","timestamp":1752237513000},"page":"1194-1202","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5141-5295","authenticated-orcid":false,"given":"Michelle","family":"Echevarria","sequence":"first","affiliation":[{"name":"1Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3004-3285","authenticated-orcid":false,"given":"Robin","family":"Park","sequence":"additional","affiliation":[{"name":"2Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6417-2483","authenticated-orcid":false,"given":"Jimmy J.","family":"Caudell","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2307-0330","authenticated-orcid":false,"given":"Youngchul","family":"Kim","sequence":"additional","affiliation":[{"name":"3Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4745-2592","authenticated-orcid":false,"given":"George Q.","family":"Yang","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1302-9577","authenticated-orcid":false,"given":"Kedar","family":"Kirtane","sequence":"additional","affiliation":[{"name":"2Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9417-0340","authenticated-orcid":false,"given":"Ritu","family":"Chaudhary","sequence":"additional","affiliation":[{"name":"2Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6282-0640","authenticated-orcid":false,"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[{"name":"4Naveris, Inc., Waltham, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6295-2694","authenticated-orcid":false,"given":"Antonio L.","family":"Amelio","sequence":"additional","affiliation":[{"name":"2Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida."},{"name":"5Department of Tumor Microenvironment and Metastasis, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5440-8859","authenticated-orcid":false,"given":"Anna R.","family":"Giuliano","sequence":"additional","affiliation":[{"name":"6Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5199-4306","authenticated-orcid":false,"given":"Christine H.","family":"Chung","sequence":"additional","affiliation":[{"name":"2Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"2025072203555445300_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"2025072203555445300_bib2","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"2025072203555445300_bib3","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol"},{"key":"2025072203555445300_bib4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.15585\/mmwr.mm6833a3","article-title":"Human papillomavirus-attributable cancers - United States, 2012-2016","volume":"68","author":"Senkomago","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025072203555445300_bib5","article-title":"Head and neck cancers, version 2.2025","author":"National Comprehensive Cancer Network (NCCN)"},{"key":"2025072203555445300_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"2025072203555445300_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"2025072203555445300_bib8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2021.04.015","article-title":"Randomized trial of radiation therapy with weekly cisplatin or cetuximab in low-risk HPV-associated oropharyngeal cancer (TROG 12.01) - a Trans-Tasman Radiation Oncology Group Study","volume":"111","author":"Rischin","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025072203555445300_bib9","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/hed.28057","article-title":"Circulating tumor HPV-DNA in the management of HPV-positive oropharyngeal carcinoma: a systematic review","volume":"47","author":"Chen","year":"2025","journal-title":"Head Neck"},{"key":"2025072203555445300_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/jamaoncol.2024.1530","article-title":"Neoadjuvant nivolumab plus chemotherapy followed by response-adaptive therapy for HPV+ oropharyngeal cancer: OPTIMA II phase 2 open-label nonrandomized controlled trial","volume":"10","author":"Rosenberg","year":"2024","journal-title":"JAMA Oncol"},{"key":"2025072203555445300_bib11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1078-0432.CCR-21-2338","article-title":"Early HPV ctDNA kinetics and imaging biomarkers predict therapeutic response in p16+ oropharyngeal squamous cell carcinoma","volume":"28","author":"Cao","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2025072203555445300_bib12","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-19-0211","article-title":"Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal cancer","volume":"25","author":"Chera","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2025072203555445300_bib13","doi-asserted-by":"crossref","first-page":"107179","DOI":"10.1016\/j.oraloncology.2025.107179","article-title":"Circulating tumor DNA determines induction chemotherapy response in HPV associated oropharyngeal squamous cell carcinoma: a pilot study","volume":"161","author":"Huttinger","year":"2025","journal-title":"Oral Oncol"},{"key":"2025072203555445300_bib14","doi-asserted-by":"crossref","first-page":"106438","DOI":"10.1016\/j.jinf.2025.106438","article-title":"Efficacy of oral rinse and other detection methods in detecting oral human papillomavirus infections: the Oromouth cohort study","volume":"90","author":"Hillier","year":"2025","journal-title":"J Infect"},{"key":"2025072203555445300_bib15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jamaoto.2019.0119","article-title":"Human papillomavirus genotype detection in oral gargle samples among men with newly diagnosed oropharyngeal squamous cell carcinoma","volume":"145","author":"Martin-Gomez","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2025072203555445300_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ijc.33798","article-title":"Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary","volume":"150","author":"Tanaka","year":"2022","journal-title":"Int J Cancer"},{"key":"2025072203555445300_bib17","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jamaoncol.2019.0439","article-title":"Association of oral human papillomavirus DNA persistence with cancer progression after primary treatment for oral cavity and oropharyngeal squamous cell carcinoma","volume":"5","author":"Fakhry","year":"2019","journal-title":"JAMA Oncol"},{"key":"2025072203555445300_bib18","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0167-8140(23)08520-1","article-title":"OC-0106 prospective trial of personalized fractionation in low-risk HPV positive oropharyngeal cancerroph","volume":"182","author":"Caudell","year":"2023","journal-title":"Radiother Oncol"},{"key":"2025072203555445300_bib19","doi-asserted-by":"crossref","first-page":"E683","DOI":"10.1016\/j.ijrobp.2017.06.2249","article-title":"Mid-treatment nodal response is associated with outcome in head and neck squamous cell cancer","volume":"99","author":"Latifi","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025072203555445300_bib20","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1002\/cam4.4757","article-title":"Methylation of HPV16 and EPB41L3 in oral gargles and the detection of early and late oropharyngeal cancer","volume":"11","author":"Dickey","year":"2022","journal-title":"Cancer Med"},{"key":"2025072203555445300_bib21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/diagnostics13040725","article-title":"Analytical validation of NavDx, a cfDNA-based fragmentomic profiling assay for HPV-driven cancers","volume":"13","author":"Gunning","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"2025072203555445300_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.oraloncology.2019.03.019","article-title":"Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases","volume":"92","author":"Martin-Gomez","year":"2019","journal-title":"Oral Oncol"},{"key":"2025072203555445300_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jviromet.2015.01.001","article-title":"The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra","volume":"215-216","author":"Geraets","year":"2015","journal-title":"J Virol Methods"},{"key":"2025072203555445300_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jviromet.2014.01.012","article-title":"Evaluation of an automated SPF10-LiPA25 assay for detection and typing of human papillomavirus in archival samples","volume":"199","author":"Cornall","year":"2014","journal-title":"J Virol Methods"},{"key":"2025072203555445300_bib25","doi-asserted-by":"crossref","first-page":"21226","DOI":"10.1038\/s41598-023-48506-6","article-title":"Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis","volume":"13","author":"Kentnowski","year":"2023","journal-title":"Sci Rep"},{"key":"2025072203555445300_bib26","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1016\/j.ijrobp.2024.07.1612","article-title":"The impact of circulating tumor human papillomavirus (HPV) DNA clearance kinetics on disease outcomes during chemoradiation in patients with HPV-associated oropharyngeal cancer","volume":"120","author":"Jhawar","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025072203555445300_bib27","doi-asserted-by":"crossref","first-page":"100199","DOI":"10.1016\/j.pvr.2020.100199","article-title":"Oral HPV prevalence assessment by linear Array vs. SPF(10) PCR-DEIA-LiPA(25) system in the HPV infection in men (HIM) study","volume":"9","author":"Bettampadi","year":"2020","journal-title":"Papillomavirus Res"},{"key":"2025072203555445300_bib28","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(09)61567-1","article-title":"Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6\u00b74 years","volume":"374","author":"GlaxoSmithKline Vaccine HPV-007 Study Group","year":"2009","journal-title":"Lancet"},{"key":"2025072203555445300_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13046-024-03137-1","article-title":"The landscape of circulating tumor HPV DNA and TTMV-HPVDNA for surveillance of HPV-oropharyngeal carcinoma: systematic review and meta-analysis","volume":"43","author":"Campo","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"2025072203555445300_bib30","doi-asserted-by":"crossref","first-page":"105805","DOI":"10.1016\/j.oraloncology.2022.105805","article-title":"Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer","volume":"128","author":"Mattox","year":"2022","journal-title":"Oral Oncol"},{"key":"2025072203555445300_bib31","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/hed.24729","article-title":"Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines","volume":"39","author":"Walline","year":"2017","journal-title":"Head Neck"},{"key":"2025072203555445300_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1541-7786.MCR-17-0153","article-title":"HPV integration in HNSCC correlates with survival outcomes, immune response signatures, and candidate drivers","volume":"16","author":"Koneva","year":"2018","journal-title":"Mol Cancer Res"},{"key":"2025072203555445300_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.oraloncology.2018.03.015","article-title":"Patients with integrated HPV16 in head and neck cancer show poor survival","volume":"80","author":"Nulton","year":"2018","journal-title":"Oral Oncol"},{"key":"2025072203555445300_bib34","doi-asserted-by":"crossref","first-page":"113336","DOI":"10.1016\/j.ejca.2023.113336","article-title":"Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: a single-arm, phase 2 trial","volume":"194","author":"Guo","year":"2023","journal-title":"Eur J Cancer"},{"key":"2025072203555445300_bib35","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/jpm11111124","article-title":"Dynamics-adapted radiotherapy dose (DARD) for head and neck cancer radiotherapy dose personalization","volume":"11","author":"Zahid","year":"2021","journal-title":"J Pers Med"},{"key":"2025072203555445300_bib36","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1158\/1078-0432.CCR-24-3053","article-title":"A prospective trial of biomarker-guided surveillance for HPV-positive oropharynx cancer using plasma tumor tissue-modified viral HPV DNA","volume":"31","author":"Rettig","year":"2024","journal-title":"Clin Cancer Res"},{"key":"2025072203555445300_bib37","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1158\/1078-0432.CCR-23-1478","article-title":"Negative predictive value of circulating tumor tissue modified viral (TTMV)-HPV DNA for HPV-driven oropharyngeal cancer surveillance","volume":"29","author":"Hanna","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2025072203555445300_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41591-024-03216-y","article-title":"Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma","volume":"31","author":"Black","year":"2025","journal-title":"Nat Med"},{"key":"2025072203555445300_bib39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41571-024-00985-w","article-title":"Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?","volume":"22","author":"Normanno","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"2025072203555445300_bib40","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3390\/cancers15041248","article-title":"Prognostic significance of the post-treatment neutrophil-to-lymphocyte ratio in pharyngeal cancers treated with concurrent chemoradiotherapy","volume":"15","author":"Yun","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2025072203555445300_bib41","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-24-2525","article-title":"Direct comparison of alternative blood-based approaches for early detection and diagnosis of HPV-associated head and neck cancers","author":"Bryan","year":"2025  20","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0180\/3630786\/crc-25-0180.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/7\/1194\/3632626\/crc-25-0180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/7\/1194\/3632626\/crc-25-0180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T07:56:03Z","timestamp":1753170963000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/7\/1194\/763723\/Plasma-Cell-Free-Human-Papillomavirus-DNA-and-Oral"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0180","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.29616886","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29616895","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29616892","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29616907","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29616904","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29616901","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29616889","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29616910","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29616898","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7941061","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}